Combined p53 and MDM2 biomarker analysis shows a unique pattern of expression associated with poor prognosis in patients with renal cell carcinoma undergoing radical nephrectomy

p53 and MDM2 in renal cell carcinoma

(2010) Aidan P. Noon et al.   CANCER

MDM2 promotes cell motility and invasiveness through a RING-finger independent mechanism

(2010) Radosław Polański et al.   FEBS LETTERS

Molecular Signatures of Localized Clear Cell Renal Cell Carcinoma to Predict Disease-Free Survival after Nephrectomy

(2009) T. Klatte et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Suppression of Hypoxia-Inducible Factor 2  Restores p53 Activity via Hdm2 and Reverses Chemoresistance of Renal Carcinoma Cells

(2009) A. M. Roberts et al.   CANCER RESEARCH

Diagnostic and Prognostic Molecular Markers for Renal Cell Carcinoma: A Critical Appraisal of the Current State of Research and Clinical Applicability

(2009) Christian Eichelberg et al.   EUROPEAN UROLOGY

p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug

(2009) Shu-Ping Wang et al.   NATURE CELL BIOLOGY

Small-Molecule Inhibitors of the MDM2-p53 Protein-Protein Interaction to Reactivate p53 Function: A Novel Approach for Cancer Therapy

(2008) Sanjeev Shangary et al.   Annual Review of Pharmacology and Toxicology

Regulation of Angiogenic Factors by HDM2 in Renal Cell Carcinoma

(2008) V. A. Carroll et al.   CANCER RESEARCH